Cyclophosphamide is a synthetic antineoplastic agent classified as an alkylating medication. Its therapeutic role is to interfere with the replication of rapidly dividing cancer cells, thereby slowing tumor growth. The drug is administered intravenously and is metabolized in the liver to produce active metabolites that affect dna. These metabolites create cross-links between dna strands which prevent proper strand separation during cell division. By halting dna replication the medication leads to cell death primarily in tissues with high turnover such as bone marrow and lymphoid organs. This mechanism also suppresses overactive immune responses, making it useful in certain autoimmune diseases.

Cyclophosphamide is an alkylating agent used in chemotherapy and immunosuppressive therapy. The drug is administered orally or intravenously and is converted in the body to active metabolites that target rapidly dividing cells. Its primary therapeutic role is the treatment of various cancers such as leukemia, lymphoma, and solid tumors. Additionally, Cyclophosphamide can suppress immune function by eliminating proliferative lymphocytes. The compound exerts its effect by adding an alkyl group to the guanine bases of dna. This alkylation prevents dna replication and triggers apoptosis in susceptible cells. As a prodrug, Cyclophosphamide requires hepatic activation to form phosphoramide mustard and acrolein. These metabolites bind to dna strands, cross-link them, and ultimately inhibit cell proliferation.

Cyclophosphamide is a chemotherapy medication used to treat various cancers and autoimmune disorders. It works by interfering with dna replication in rapidly dividing cells. Because it affects both cancerous and healthy cells it can produce a range of side effects. Nausea and vomiting are among the most frequently reported gastrointestinal reactions. Hair loss can occur as the drug impacts rapidly growing hair follicles. A decrease in blood cell production may lead to fatigue, increased infection risk, and easy bruising. Some patients also experience bladder irritation or a temporary decline in kidney function.

Cyclophosphamide commonly causes bone marrow suppression leading to reduced white blood cell counts. Patients may experience nausea, vomiting, and loss of appetite during treatment. Hair loss is frequently reported as a side effect of Cyclophosphamide therapy. The drug can irritate the bladder causing hematuria or painful urination. Fatigue is a frequent complaint among individuals receiving Cyclophosphamide. Infections are more likely due to the compromised immune system caused by the medication. Some patients develop skin rashes that may range from mild to severe.